Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Vascular Health and Risk Management Volume 3, 2007 - Issue 4

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Review

PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study

Erland Erdmann1 University of CologneCologne, GermanyCorrespondence[email protected]

John Dormandy2 Department of Clinical Vascular Research, St Georges HospitalLondon, UK

Robert Wilcox3 Department of Cardiovascular Medicine, Queen’s Medical Centre, University HospitalNottingham, UK

Massimo Massi-Benedetti4 University of Perugia, Medicine and Metabolic DiseasesPerugia, Italy

Bernard Charbonnel5 Clinique d’Endocrinologie, Hôtel Dieu, Nantes Cedex 1France

Pages 355-370 | Published online: 24 Dec 2022

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Melissa A. Davidson, Donald R. Mattison, Laurent Azoulay & Daniel Krewski. (2018) Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future. Critical Reviews in Toxicology 48:1, pages 52-108.
Read now

CHIN-HSIAO TSENG & FARN-HSUAN TSENG. (2012) Peroxisome Proliferator-Activated Receptor Agonists and Bladder Cancer: Lessons from Animal Studies. Journal of Environmental Science and Health, Part C 30:4, pages 368-402.
Read now

Lisa M Younk, Lisa Uhl & Stephen N Davis. (2011) Pharmacokinetics, efficacy and safety of aleglitazar for the treatment of type 2 diabetes with high cardiovascular risk. Expert Opinion on Drug Metabolism & Toxicology 7:6, pages 753-763.
Read now

Pedro de Pablos-Velasco. (2010) Pioglitazone: beyond glucose control. Expert Review of Cardiovascular Therapy 8:8, pages 1057-1067.
Read now

Cyrus V Desouza, Lindsey Rentschler & Vivian Fonseca. (2009) Peroxisome proliferator-activated receptors as stimulants of angiogenesis in cardiovascular disease and diabetes. Diabetes, Metabolic Syndrome and Obesity 2, pages 165-172.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references